AI assistant
Icade — Capital/Financing Update 2021
Jul 27, 2021
1424_iss_2021-07-27_968be0c3-11a9-44b9-8734-285eb4020f79.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
CONSULTATION OF THE NOTEHOLDERS IN THE CONTEXT OF THE CONTEMPLATED INITIAL PUBLIC OFFERING OF ICADE SANTÉ. APPROBATION OF THE CHANGE OF ICADE SANTÉ CORPORATE FORM AND OTHER AMENDMENTS TO THE BY-LAWS.
In the context of the contemplated initial public offering of Icade Santé on the regulated market of Euronext Paris by the end of 2021, subject to market conditions, announced on 7 June 2021 by Icade SA, the majority shareholder of Icade Santé holding 58.30% of its share capital, the holders of the EUR 500,000,000 notes issued on 4 November 2019 by Icade Santé bearing interest at a rate of 0.875 per cent and maturing on 4 November 2029 – ISIN : FR0013457967 (the "Notes") convened today in a general meeting on first convocation1 have approved :
- (i) the change of Icade Santé's corporate form from a société par actions simplifiée to a société anonyme à conseil d'administration ;
- (ii) the extension of the current corporate purpose of Icade Santé (which is currently limited to France), to international activities; and
- (iii) other amendments to the by-laws.
The change of corporate form and the abovementioned amendments to the by-laws would enter into force from the date of approval by the French Autorité des Marchés Financiers of the prospectus relating to the admission of Icade Santé's shares to trading on the regulated market of Euronext Paris.
Icade Santé invites the holders of the Notes to consult the section dedicated to the general meeting of the holders of Notes on the company's website (www.icade-sante.fr).
Disclaimer
This press release does not contain and does not constitute an offer to sell securities, or an invitation or the solicitation to invest in securities in France, in the United States or in any other jurisdiction.
ABOUT ICADE SANTÉ
With a portfolio worth €5.5 billion excluding duties (100%) as of 30 June 2021, Icade Santé is the leading investor in private healthcare facilities in France. A 58.3% owned subsidiary of the Icade Group, Icade Santé draws on its proven expertise, its long-term shareholders as well as its extensive knowledge of the real estate value chain. Since 2018, Icade Santé has pursued a strategy of diversification into the nursing home segment.
Icade Santé is rated BBB+ with a stable outlook by rating agency S&P.
The text of this press release as well as the consolidated financial statements prepared in accordance with IFRS are available on the Icade Santé website: https://icade-sante.fr
CONTACTS
Yoann Nguyen Head of Investors Relations +33(0)6 31 58 97 31 [email protected]
Etienne Maurer Deputy CFO +33(0)1 41 57 79 02 [email protected]
1 See Icade Santé's press release of July 9, 2021.